Optimum cycles of induction chemotherapy in concurrent chemo-radiotherapy management of unresectable stage III non-small cell lung cancer: Results from a single institutional database

Induction chemotherapy (IC) prior to concurrent chemo-radiotherapy is the recommended treatment for unresectable stage III non-small cell lung cancer (NSCLC). However, the optimum number of IC cycles for improved survival outcomes is still not known. Here, we assessed the efficacy of 2 or more cycle...

Descripción completa

Detalles Bibliográficos
Autores principales: Yacouba, Mohamed Bassirou Moukeila, Feng, Maohui, Thokerunga, Erick, Bongolo, Christian Cedric, Gado, Adamou Foumakoye, He, Feng, Ke, Jianjuan, Zhang, Zongze, Wang, Yanlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174407/
https://www.ncbi.nlm.nih.gov/pubmed/37171312
http://dx.doi.org/10.1097/MD.0000000000033760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174407/
https://www.ncbi.nlm.nih.gov/pubmed/37171312
http://dx.doi.org/10.1097/MD.0000000000033760

Ejemplares similares